Ribociclib 600mg Clinical Trials
3 recruitingDrug
Phase 12Phase 31Phase 21
Showing 1–3 of 3 trials
Recruiting
Phase 1Phase 2
Ribociclib for HR-positive HER2-negative Metastatic Breast Cancer
Breast Cancer
Nagoya City University86 enrolled1 locationNCT07164976
Recruiting
Phase 3
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
Metastatic Breast Cancer
American Society of Clinical Oncology500 enrolled67 locationsNCT06377852
Recruiting
Phase 1
First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer
Breast CancerMetastatic Breast CancerHER2-negative Breast Cancer+4 more
Relay Therapeutics, Inc.930 enrolled37 locationsNCT05216432